Welcome to our dedicated page for Axcelis Tech Ord news (Ticker: ACLS), a resource for investors and traders seeking the latest updates and insights on Axcelis Tech Ord stock.
The Axcelis Technologies Inc (ACLS) news page on Stock Titan aggregates company announcements, industry event participation and regulatory disclosures focused on its role in the semiconductor equipment market. Axcelis describes itself as a leading supplier of enabling ion implantation solutions for the semiconductor industry, with more than 45 years of experience providing high-productivity systems and lifecycle support.
Investors and industry followers can use this page to monitor Axcelis’ updates on product launches, technology platforms and market engagement. Recent news has highlighted the introduction of the Purion Power Series+ ion implant platform for next generation power devices, including silicon carbide (SiC) power devices and superjunction architectures, as well as the GSD Ovation ES high current implanter for engineered substrates. Company releases also cover its participation in major industry events such as SEMICON Japan and the International Conference on Silicon Carbide and Related Materials (ICSCRM), where Axcelis technologists present technical work on SiC and related materials.
The feed also includes financial and corporate developments, such as quarterly results announcements, conference call schedules and Axcelis’ participation in investor conferences. A significant recent development is the all-stock merger agreement with Veeco Instruments Inc., under which Veeco is expected to become a wholly owned subsidiary of Axcelis, subject to regulatory and shareholder approvals.
By following this ACLS news page, readers can track Axcelis’ communications on its ion implantation product portfolio, aftermarket strategy, global customer engagement and planned combination with Veeco, all drawn from official press releases and SEC-referenced materials.
Axcelis Technologies, Inc. (Nasdaq: ACLS) will release its second quarter 2020 financial results on August 4, 2020, at 4:00 p.m. ET. A conference call to discuss these results is scheduled for August 5, 2020, at 8:30 a.m. ET. Interested parties can join the call via an audio webcast on the Investors page of Axcelis' website or by dialing 866.588.8911. Axcelis, headquartered in Beverly, Mass., specializes in ion implantation systems for the semiconductor industry.
Axcelis Technologies (Nasdaq: ACLS) announced the shipment of its third Purion Dragon™ system to a leading memory manufacturer for DRAM applications, and the first Purion XEmax™ system to a CMOS image sensor maker. Both shipments occurred in Q2 and reflect the company's focus on market segmentation and technology innovation. CEO Mary Puma highlighted these developments as key to reaching their growth targets of $550M to $650M. The Purion Dragon™ targets advanced memory and logic applications, while the Purion XEmax™ is designed for high-performance image sensor applications, enhancing photodiode performance.